Morphoceuticals
Morphoceuticals is a TechBio company pioneering regenerative medicine by building the first atlas of the bioelectrome, the body's communication network that controls tissue repair and organ regeneration. Using multi-omics, bioelectric profiling, and AI, they aim to activate dormant systems for regeneration to treat traumatic injuries, degenerative diseases, and organ failure. Their AI-driven technology modulates ion channels to influence bioelectric signaling, enabling novel discoveries with significant health impacts. The company is led by experienced executives and has garnered media attention for its innovative approach to reversing aging and promoting regeneration.
Morphoceuticals
Morphoceuticals is a TechBio company pioneering regenerative medicine by building the first atlas of the bioelectrome, the body's communication network that controls tissue repair and organ regeneration. Using multi-omics, bioelectric profiling, and AI, they aim to activate dormant systems for regeneration to treat traumatic injuries, degenerative diseases, and organ failure. Their AI-driven technology modulates ion channels to influence bioelectric signaling, enabling novel discoveries with significant health impacts. The company is led by experienced executives and has garnered media attention for its innovative approach to reversing aging and promoting regeneration.
TL;DR
Sector: Biotechnology (TechBio, regenerative medicine)
Founded: 2020
Headquarters: Boston area (Marblehead / Medford, MA referenced)
Core technology: AI-guided bioelectric profiling, multi-omics, electroceutical modulation of ion channels
Notable funding: Seed rounds with investors including Juvenescence, Prime Movers Lab, Ferocity Capital
Company Overview
Problem Domain
Regenerative medicine, traumatic injury repair, degenerative disease, organ failure
Founded
2020
Industry
Biotechnology
Funding Track Record
Most recent disclosed seed round recorded on Feb 27, 2025.
Seed round recorded on Oct 7, 2024.
Seed round on Jan 23, 2023 with Prime Movers Lab participation.
Investor Signal
“Investors include Juvenescence, Prime Movers Lab, and Ferocity Capital”